FDA Approves Novartis’ New IL-17A-Blocking Psoriasis Drug Cosentyx
Novartis' Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.
Tag: Novartis
All
LatestSorry, No Posts Found
All
Latest
Establishment Labs Expands Minimally Invasive Breast Lines and Unveils Tissue Preservation Data
New sizes for the Mia and Preserve systems expand the company’s minimally invasive breast offerings. The company also presented new clinical data on breast tissue preservation to more than 1,000 plastic surgeons.
